Royalty Pharma (RPRX)
NASDAQ: RPRX
· Real-Time Price · USD
35.88
-0.04 (-0.11%)
At close: Aug 19, 2025, 10:45 AM
Royalty Pharma Revenue
Royalty Pharma reported an annual revenue of $2.26B, reflecting a -3.85% growth. For the quarter ending June 30, 2025, Royalty Pharma generated $578.66M in revenue.
Revenue (ttm)
2.26B
Revenue Growth
-3.85%
Price / Sales Ratio
5.04
Revenue / Employee
30.19M
Employees
75
Market Cap
15.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 2.26B | -3.85% |
| Dec 31, 2023 | 2.35B | +5.24% |
| Dec 31, 2022 | 2.24B | -2.28% |
| Dec 31, 2021 | 2.29B | +7.89% |
| Dec 31, 2020 | 2.12B | +16.96% |
| Dec 31, 2019 | 1.81B | +1.08% |
| Dec 31, 2018 | 1.79B | +12.33% |
| Dec 31, 2017 | 1.6B | -14.89% |
| Dec 31, 2016 | 1.88B | +13.62% |
| Dec 31, 2015 | 1.65B | n/a |